168 related articles for article (PubMed ID: 11985976)
1. Effect of platelet-activating factor antagonists (BN-52021, WEB-2170, and BB-882) on bacterial translocation in acute pancreatitis.
de Souza LJ; Sampietre SN; Assis RS; Knowles CH; Leite KR; Jancar S; Monteiro Cunha JE; Machado MC
J Gastrointest Surg; 2001; 5(4):364-70. PubMed ID: 11985976
[TBL] [Abstract][Full Text] [Related]
2. Effect of a platelet-activating factor antagonist on pancreatitis-associated gut barrier dysfunction in rats.
Andersson R; Wang X; Sun Z; Deng X; Soltesz V; Ihse I
Pancreas; 1998 Aug; 17(2):107-19. PubMed ID: 9700940
[TBL] [Abstract][Full Text] [Related]
3. The effect of lexipafant on bacterial translocation in acute necrotizing pancreatitis in rats.
Liu Q; Djuricin G; Rossi H; Bewsey K; Nathan C; Gattuso P; Weinstein RA; Prinz RA
Am Surg; 1999 Jul; 65(7):611-6; discussion 617. PubMed ID: 10399968
[TBL] [Abstract][Full Text] [Related]
4. Effect of PAF antagonists on cerulein-induced pancreatitis.
Jancar S; Abdo EE; Sampietre SN; Kwasniewski FH; Coelho AM; Bonizzia A; Machado MC
J Lipid Mediat Cell Signal; 1995 Jan; 11(1):41-9. PubMed ID: 7537159
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of recombinant platelet-activating factor acetylhydrolase and BN 52021 on bacterial translocation in cerulein-induced pancreatitis.
Bedirli A; Gokahmetoglu S; Sakrak O; Soyuer I; Ince O; Sozuer E
Eur Surg Res; 2004; 36(3):136-41. PubMed ID: 15178901
[TBL] [Abstract][Full Text] [Related]
6. Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat.
Zhou WG; Chao W; Levine BA; Olson MS
Am J Pathol; 1990 Dec; 137(6):1501-8. PubMed ID: 1701964
[TBL] [Abstract][Full Text] [Related]
7. Role of platelet-activating factor in pancreatitis-associated acute lung injury in the rat.
Zhou W; McCollum MO; Levine BA; Olson MS
Am J Pathol; 1992 Apr; 140(4):971-9. PubMed ID: 1562055
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor antagonists decrease the inflammatory nociceptive response in rats.
Teather LA; Magnusson JE; Wurtman RJ
Psychopharmacology (Berl); 2002 Oct; 163(3-4):430-3. PubMed ID: 12373444
[TBL] [Abstract][Full Text] [Related]
9. The effect of platelet activating factor antagonist (BN 52021) on acute experimental pancreatitis with reference to multiorgan oxidative stress.
Dabrowski A; Gabryelewicz A; Chyczewski L
Int J Pancreatol; 1995 Apr; 17(2):173-80. PubMed ID: 7542692
[TBL] [Abstract][Full Text] [Related]
10. Effects of platelet activating factor antagonist (BN50739) on gut mucosal injury in acute severe pancreatitis in pigs.
Zhu W; Li J; Tu W; Li N
Chin Med J (Engl); 2000 Aug; 113(8):756-8. PubMed ID: 11776064
[TBL] [Abstract][Full Text] [Related]
11. Enterolobin induces rat paw oedema independently of PAF-acether.
Castro-Faria-Neto HC; Cordeiro RS; Martins MA; Correia-Da-Silva AC; Bozza PT; Sousa MV; Morhy L
Mem Inst Oswaldo Cruz; 1991; 86 Suppl 2():129-31. PubMed ID: 1841984
[TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor mediates pancreatic function derangement in caerulein-induced pancreatitis in rats.
Alonso R; Montero A; Arévalo M; García LJ; Sánchez-Vicente C; Rodríguez-Nodal F; López-Novoa JM; Calvo JJ
Clin Sci (Lond); 1994 Jul; 87(1):85-90. PubMed ID: 7520381
[TBL] [Abstract][Full Text] [Related]
13. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P
Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286
[TBL] [Abstract][Full Text] [Related]
14. Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock.
De Kimpe SJ; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Dec; 116(8):3191-8. PubMed ID: 8719795
[TBL] [Abstract][Full Text] [Related]
15. Effect of platelet-activating factor antagonist WEB 2086 on microcirculatory disorders in acute experimental pancreatitis of graded severity.
Mann O; Tiefenbacher WJ; Kaifi J; Schneider C; Kluth D; Bloechle C; Yekebas E; Izbicki JR; Strate T
Pancreas; 2009 Jan; 38(1):58-64. PubMed ID: 18695628
[TBL] [Abstract][Full Text] [Related]
16. Acute pancreatitis affects non-parenchymal liver cells by a mechanism dependent on platelet-activating factor.
Souza LJ; Shio MT; Molan NA; Machado MC; Jancar S
Pancreatology; 2007; 7(1):67-73. PubMed ID: 17449968
[TBL] [Abstract][Full Text] [Related]
17. Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant.
Leveau P; Wang X; Sun Z; Börjesson A; Andersson E; Andersson R
Biochem Pharmacol; 2005 May; 69(9):1325-31. PubMed ID: 15826603
[TBL] [Abstract][Full Text] [Related]
18. The effect of platelet activating factor antagonist BN 52021 on bacterial translocation and ICAM-I expression in experimental obstructive jaundice.
Akyürek N; Salman B; Irkörücü O; Tezcaner T; Azili C; Erdem O; Akca G; Akin O; Tatlicioglu E
J Invest Surg; 2005; 18(5):247-56. PubMed ID: 16249168
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of lexipafant, a PAF antagonist on gut barrier dysfunction caused by intestinal ischemia and reperfusion in rats.
Sun Z; Wang X; Deng X; Lasson A; Soltesz V; Börjesson A; Andersson R
Dig Surg; 2000; 17(1):57-65. PubMed ID: 10720833
[TBL] [Abstract][Full Text] [Related]
20. Influence of a platelet-activating factor antagonist on severe pancreatitis in two experimental models.
Leonhardt U; Fayyazzi A; Seidensticker F; Stöckmann F; Söling HD; Creutzfeldt W
Int J Pancreatol; 1992 Oct; 12(2):161-6. PubMed ID: 1460331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
